Skip to main content
NCBI home page
Journal of Clinical Microbiology logoLink to Journal of Clinical Microbiology
. 1983 Jul;18(1):154–159. doi: 10.1128/jcm.18.1.154-159.1983

Radioimmunoassay and opsonic antibody responses to pneumococcal capsular polysaccharide vaccine in serum and ascitic fluid of cirrhotic patients.

M S Simberkoff, G S Schiffman, J R Spicehandler, N H Moldover, J J Rahal Jr
PMCID: PMC270760  PMID: 6885986

Abstract

Pneumococcal capsular polysaccharide vaccine was administered to 19 cirrhotic patients and to 25 control subjects. Radioimmunoassay antibody concentration and opsonic titers (OT) were measured in sera and ascites collected before and 3 to 4 weeks after inoculation. The geometric mean antibody concentrations in prevaccination sera from the cirrhotic patients were significantly increased to types 3, 4, 7F, 8, 9N, and 12F antigens, and in postinoculation sera their geometric mean antibody concentration was increased to types 3, 9N, and 12F antigens. OT to Streptococcus pneumoniae type 3 correlated with the radioimmunoassay antibody concentration in postinoculation sera. Of 14 cirrhotic subjects, 3 had OT of greater than or equal to 4 in prevaccination sera, and the highest OT and radioimmunoassay antibody concentration were observed in postinoculation specimens from this group. Antibody and OT against S. pneumoniae type 3 were also observed in ascitic specimens. These data suggest that cirrhotic subjects respond to pneumococcal capsular polysaccharide with antibodies in both serum and ascitic fluid. However, the protective efficacy of this antibody response must be assessed by larger prospective studies.

Full text

PDF
154

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. AUSTRIAN R., GOLD J. PNEUMOCOCCAL BACTEREMIA WITH ESPECIAL REFERENCE TO BACTEREMIC PNEUMOCOCCAL PNEUMONIA. Ann Intern Med. 1964 May;60:759–776. doi: 10.7326/0003-4819-60-5-759. [DOI] [PubMed] [Google Scholar]
  2. Correia J. P., Conn H. O. Spontaneous bacterial peritonitis in cirrhosis: endemic or epidemic? Med Clin North Am. 1975 Jul;59(4):963–981. doi: 10.1016/s0025-7125(16)31995-2. [DOI] [PubMed] [Google Scholar]
  3. Curry N., McCallum R. W., Guth P. H. Spontaneous peritonitis in cirrhotic ascites. A decade of experience. Am J Dig Dis. 1974 Aug;19(8):685–692. doi: 10.1007/BF01844937. [DOI] [PubMed] [Google Scholar]
  4. DeMeo A. N., Andersen B. R. Defective chemotaxis associated with a serum inhibitor in cirrhotic patients. N Engl J Med. 1972 Apr 6;286(14):735–740. doi: 10.1056/NEJM197204062861401. [DOI] [PubMed] [Google Scholar]
  5. Fuxench-López Z., Ramírez-Ronda C. H. Pharyngeal flora in ambulatory alcoholic patients: prevalence of gram-negative bacilli. Arch Intern Med. 1978 Dec;138(12):1815–1816. doi: 10.1001/archinte.1978.03630370033017. [DOI] [PubMed] [Google Scholar]
  6. Grieco M. H., Capra J. D., Paderon H. Reduced serum beta 1c/1a globulin levels in extrarenal disease. Am J Med. 1971 Sep;51(3):340–345. doi: 10.1016/0002-9343(71)90269-5. [DOI] [PubMed] [Google Scholar]
  7. Heidelberger M., Dudman W. F., Nimmich W. Immunochemical relationships of certain capsular polysaccharides of Klebsiella, pneumococci and Rhizobia. J Immunol. 1970 Jun;104(6):1321–1328. [PubMed] [Google Scholar]
  8. Heidelberger M., Dutton G. G. Cross-reactions of additional extracellular polysaccharides of Klebsiella. J Immunol. 1973 Sep;111(3):857–859. [PubMed] [Google Scholar]
  9. Mufson M. A., Kruss D. M., Wasil R. E., Metzger W. I. Capsular types and outcome of bacteremic pneumococcal disease in the antibiotic era. Arch Intern Med. 1974 Sep;134(3):505–510. [PubMed] [Google Scholar]
  10. Petz L. D. Variable mechanisms for low serum-complement in liver disease. Lancet. 1971 Nov;2(7732):1033–1034. doi: 10.1016/s0140-6736(71)90347-3. [DOI] [PubMed] [Google Scholar]
  11. Schiffman G., Douglas R. M., Bonner M. J., Robbins M., Austrian R. A radioimmunoassay for immunologic phenomena in pneumococcal disease and for the antibody response to pneumococcal vaccines. I. Method for the radioimmunoassay of anticapsular antibodies and comparison with other techniques. J Immunol Methods. 1980;33(2):133–144. doi: 10.1016/s0022-1759(80)80004-4. [DOI] [PubMed] [Google Scholar]
  12. Shelton E., Bennett W. I., Orenstein J. M. Differentiation of small numbers of mouse peritoneal cells into antibody-producing plasma cells in diffusion chambers. Exp Mol Pathol. 1976 Apr;24(2):220–235. doi: 10.1016/0014-4800(76)90007-1. [DOI] [PubMed] [Google Scholar]
  13. Simberkoff M. S. Evaluation of pneumococcal vaccine. JAMA. 1981 Sep 18;246(12):1299–1300. [PubMed] [Google Scholar]
  14. Simberkoff M. S., Schiffman G., Katz L. A., Spicehandler J. R., Moldover N. H., Rahal J. J., Jr Pneumococcal capsular polysaccharide vaccination in adult chronic hemodialysis patients. J Lab Clin Med. 1980 Aug;96(2):363–370. [PubMed] [Google Scholar]
  15. Smit P., Oberholzer D., Hayden-Smith S., Koornhof H. J., Hilleman M. R. Protective efficacy of pneumococcal polysaccharide vaccines. JAMA. 1977 Dec 12;238(24):2613–2616. [PubMed] [Google Scholar]
  16. Van Epps D. E., Strickland R. G., Williams R. C., Jr Inhibitors of leukocyte chemotaxis in alcoholic liver disease. Am J Med. 1975 Aug;59(2):200–207. doi: 10.1016/0002-9343(75)90354-x. [DOI] [PubMed] [Google Scholar]
  17. Weinstein M. P., Iannini P. B., Stratton C. W., Eickhoff T. C. Spontaneous bacterial peritonitis. A review of 28 cases with emphasis on improved survival and factors influencing prognosis. Am J Med. 1978 Apr;64(4):592–598. doi: 10.1016/0002-9343(78)90578-8. [DOI] [PubMed] [Google Scholar]
  18. Young L. S., Stevens P. Cross-protective immunity to Gram-negative bacilli: studies with core glycolipid of Salmonella minnesota and antigens of Streptococcus pneumoniae. J Infect Dis. 1977 Aug;136 (Suppl):S174–S180. doi: 10.1093/infdis/136.supplement.s174. [DOI] [PubMed] [Google Scholar]

Articles from Journal of Clinical Microbiology are provided here courtesy of American Society for Microbiology (ASM)

RESOURCES